Sale of Ozempic Knockoffs Is Supposed to End Soon. Telehealth Companies Aren’t Happy.
Pharmaceutical giants are squaring off against telehealth companies and pharmacies selling custom-made versions of the hot ...
Compound versions of some weight loss drugs to be restricted
Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to ...
Some People Are ‘Microdosing’ Ozempic—and Doctors Are Wary of the New Weight Loss Trend
More and more people are microdosing Ozempic, a popular weight loss drug, due to high costs and uncomfortable side effects.
Healthline1d
Compounding Pharmacies to Stop Making Ozempic, Zepound Knockoffs: What to Know
The FDA ordered compounding pharmacies to stop making copycat versions of weight loss drugs like Ozempic and Zepbound now ...
Thank God I’ve stopped microdosing Ozempic – this is what it’s really like
Thank God I’ve stopped microdosing Ozempic – this is what it’s really like - COMMENT: The new craze of using ...
There's A Surprising New Side Effect Of Ozempic That Doctors Want You To Know About
A new study links semaglutide, the active ingredient in Ozempic and Wegovy, to a higher risk of hair loss, especially in ...
Novo Nordisk's Ozempic successor disappointed Wall Street again
Novo Nordisk (NVO) released clinical trial results for its potential Ozempic successor on Monday, disappointing Wall Street ...
Does Ozempic Really Cause Thyroid Cancer? What the Science Actually Says
Recent research throws into question whether GLP-1 drugs increase the risk of certain types of thyroid cancer.
Weight-loss drug Mounjaro in India: Is it better than Ozempic?
US pharmaceutical company Eli Lilly has launched Mounjaro, a diabetes and weight-loss drug, in India. Priced at Rs 3,500 for a 2.5 mg vial, the ‘game-changing’ medication has debuted in the Indian ...